BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34932012)

  • 1. Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study.
    Black J; Margolin ZR; Bau G; Olson R; Iwanicki JL; Dart RC
    JMIR Public Health Surveill; 2021 Dec; 7(12):e29187. PubMed ID: 34932012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Online Conversation Monitoring to Understand the Opioid Epidemic: Epidemiological Surveillance Study.
    Black JC; Margolin ZR; Olson RA; Dart RC
    JMIR Public Health Surveill; 2020 Jun; 6(2):e17073. PubMed ID: 32597786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crowdsourcing black market prices for prescription opioids.
    Dasgupta N; Freifeld C; Brownstein JS; Menone CM; Surratt HL; Poppish L; Green JL; Lavonas EJ; Dart RC
    J Med Internet Res; 2013 Aug; 15(8):e178. PubMed ID: 23956042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversion and Illicit Sale of Extended Release Tapentadol in the United States.
    Dart RC; Surratt HL; Le Lait MC; Stivers Y; Bebarta VS; Freifeld CC; Brownstein JS; Burke JJ; Kurtz SP; Dasgupta N
    Pain Med; 2016 Aug; 17(8):1490-6. PubMed ID: 26814267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring Program.
    Vosburg SK; Haynes C; Besharat A; Green JL
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1044-1052. PubMed ID: 28653782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System.
    Vosburg SK; Severtson SG; Dart RC; Cicero TJ; Kurtz SP; Parrino MW; Green JL
    J Pain; 2018 Apr; 19(4):439-453. PubMed ID: 29224919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users.
    Butler SF; Oyedele NK; Dailey Govoni T; Green JL
    JMIR Public Health Surveill; 2020 Mar; 6(1):e16038. PubMed ID: 32209533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone.
    Lebin JA; Murphy DL; Severtson SG; Bau GE; Dasgupta N; Dart RC
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):25-30. PubMed ID: 29766592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the abuse of tapentadol immediate release: the first 24 months.
    Dart RC; Cicero TJ; Surratt HL; Rosenblum A; Bartelson BB; Adams EH
    J Opioid Manag; 2012; 8(6):395-402. PubMed ID: 23264317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
    Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.
    Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L
    Drug Alcohol Depend; 2020 Jan; 206():107697. PubMed ID: 31869601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Extreme personal stress' and 'a lot of pain': Exploring the physical, mental and social contexts of extramedical pharmaceutical opioid use in Australian paramedic case descriptions.
    Wilson J; Lam T; Scott D; Crossin R; Matthews S; Smith K; Lubman DI; Nielsen S
    Drug Alcohol Rev; 2020 Nov; 39(7):870-878. PubMed ID: 32633445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia.
    Lam T; Biggs N; Xia T; Evans J; Stevens J; da Gama M; Lubman DI; Nielsen S
    BMJ Open; 2022 Apr; 12(4):e060151. PubMed ID: 35418442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing abuse potential of new analgesic medications following market release: an evaluation of Internet discussion of tapentadol abuse.
    McNaughton EC; Black RA; Weber SE; Butler SF
    Pain Med; 2015 Jan; 16(1):131-40. PubMed ID: 25244069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.
    Severtson SG; Ellis MS; Kurtz SP; Rosenblum A; Cicero TJ; Parrino MW; Gilbert MK; Buttram ME; Dasgupta N; BucherBartelson B; Green JL; Dart RC
    Drug Alcohol Depend; 2016 Nov; 168():219-229. PubMed ID: 27716575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study.
    Cepeda MS; Fife D; Ma Q; Ryan PB
    J Pain; 2013 Oct; 14(10):1227-41. PubMed ID: 23850177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the Street Prices of Prescription Opioids During the COVID-19 Pandemic.
    Mutter R; Black J; Iwanicki J
    Psychiatr Serv; 2023 Jan; 74(1):63-65. PubMed ID: 35770425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse.
    McNaughton EC; Coplan PM; Black RA; Weber SE; Chilcoat HD; Butler SF
    J Med Internet Res; 2014 May; 16(5):e119. PubMed ID: 24800858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse.
    Cepeda MS; Fife D; Kihm MA; Mastrogiovanni G; Yuan Y
    Clin J Pain; 2014 Dec; 30(12):1051-6. PubMed ID: 24370606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tapentadol Versus Oxycodone for Opioid-Related Adverse Drug Events and Clinical Outcomes After Inpatient Surgery.
    Liu S; Patanwala AE; Naylor JM; Stevens JA; Bugeja B; Begley D; Khor KE; Lau E; Adie S; Penm J
    J Pain; 2024 Feb; 25(2):466-475. PubMed ID: 37741523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.